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ABSTRACT Respiratory infection during childhood is a key risk factor in early cystic
fibrosis (CF) lung disease progression. Haemophilus influenzae and Haemophilus parain-
fluenzae are routinely isolated from the lungs of children with CF; however, little is
known about the frequency and characteristics of Haemophilus colonization in this
context. Here, we describe the detection, antimicrobial resistance (AMR), and genome
sequencing of H. influenzae and H. parainfluenzae isolated from airway samples of 147
participants aged #12years enrolled in the Australian Respiratory Early Surveillance
Team for Cystic Fibrosis (AREST CF) program, Melbourne, Australia. The frequency of
colonization per visit was 4.6% for H. influenzae and 32.1% for H. parainfluenzae, 80.3%
of participants had H. influenzae and/or H. parainfluenzae detected on at least one
visit, and using genomic data, we estimate 15.6% of participants had persistent coloni-
zation with the same strain for at least two consecutive visits. Isolates were genetically
diverse and AMR was common, with 52% of H. influenzae and 82% of H. parainfluen-
zae displaying resistance to at least one drug. The genetic basis for AMR could be
identified in most cases; putative novel determinants include a new plasmid encoding
blaTEM-1 (ampicillin resistance), a new inhibitor-resistant blaTEM allele (augmentin resist-
ance), and previously unreported mutations in chromosomally carried genes (pbp3,
ampicillin resistance; folA/folP, cotrimoxazole resistance; rpoB, rifampicin resistance).
Acquired AMR genes were more common in H. parainfluenzae than H. influenzae (51%
versus 21%, P=0.0107) and were mostly associated with the ICEHin mobile element
carrying blaTEM-1, resulting in more ampicillin resistance in H. parainfluenzae (73%
versus 30%, P=0.0004). Genomic data identified six potential instances of Haemophilus
transmission between participants, of which three involved participants who shared clinic
visit days.
IMPORTANCE Cystic fibrosis (CF) lung disease begins during infancy, and acute respira-
tory infections increase the risk of early disease development and progression. Microbes
involved in advanced stages of CF are well characterized, but less is known about early
respiratory colonizers. We report the population dynamics and genomic determinants
of AMR in two early colonizer species, namely, Haemophilus influenzae and Haemophilus
parainfluenzae, collected from a pediatric CF cohort. This investigation also reveals that
H. parainfluenzae has a high frequency of AMR carried on mobile elements that may
act as a potential reservoir for the emergence and spread of AMR to H. influenzae,
which has greater clinical significance as a respiratory pathogen in children. This study
provides insight into the evolution of AMR and the colonization of H. influenzae and H.
parainfluenzae in a pediatric CF cohort, which will help inform future treatment.
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Cystic fibrosis (CF) is a common inherited genetic disorder caused by deleteriousmutations in the cystic fibrosis transmembrane conductance regulator gene (1).
Although the disease is multisystemic, the primary cause of morbidity and mortality
results from pulmonary dysfunction. CF lung disease manifests as delayed mucociliary
clearance and mucus adhesion leading to recurrent and chronic microbial infections
(2), which elicit an adverse host inflammation response resulting in bronchiectasis and
ultimately respiratory failure (3, 4). Management of bacterial lung infections is essential
in CF disease trajectory and can be managed in part through antimicrobial therapy.
However, antimicrobial resistance (AMR) is frequently acquired through various mechanisms
and can have clinical consequences in CF patients, including reduced lung function (5–7).
There are a small number of bacterial species that predominantly cause CF lung infec-
tions, including Pseudomonas aeruginosa, Burkholderia cepacia complex, Staphylococcus
aureus, Stenotrophomonas maltophilia, and Haemophilus influenzae (8). Importantly, acute
respiratory infection in newborns with CF is an established risk factor for early disease de-
velopment and progression (9).
H. influenzae and Haemophilus parainfluenzae are among the most common Haemophilus
species that colonize the respiratory tract of children in early life (10, 11). H. influenzae is
considered an opportunistic pathogen and can cause invasive disease. Instances of invasive
H. parainfluenzae infection have also been described (12–14); however, H. parainfluenzae-
related disease is less frequently observed, and H. parainfluenzae is recognized as having a
lower pathogenic capacity than H. influenzae. Both H. influenzae and H. parainfluenzae are
routinely isolated from the respiratory tract of children with CF, particularly during episodes
of disease exacerbation (15). Although many of the classical pathogens involved in CF lung
disease have been well studied, less is known about the role of Haemophilus species during
the critical period of early childhood. Such knowledge is essential, as it is increasingly recog-
nized that CF lung disease commences soon after diagnosis in early infancy and progresses
thereafter (16, 17). Further insight into the epidemiology and resistance profiles of these
early colonizing and infecting bacteria will inform future treatment practices.
The emergence and accumulation of AMR in H. influenzae and H. parainfluenzae is
common, with the highest resistance rates reported for ampicillin (AMP; 23.9 to 58.5%
in H. influenzae, 13.2 to 50.0% in H. parainfluenzae) and cotrimoxazole (21.4 to 71.1% in
H. influenzae, 14.9 to 44.2% in H. parainfluenzae) (18–31). Generally, H. influenzae infec-
tions are treated with b-lactams, such as extended-spectrum penicillins or cephalospo-
rins (32). Other drugs are often used in combination with or as an alternative to b-lac-
tams and include antifolates, quinolones, and macrolides. Resistance to these drugs
typically arises through either acquisition of horizontally transferred resistance genes
or mutations in chromosomally encoded protein targets (32). Acquired AMR genes in
H. influenzae and H. parainfluenzae are frequently localized within mobile genetic ele-
ments, such as ICEHin or small plasmids (33–35), which appear to have facilitated the
emergence of multidrug-resistant H. influenzae and H. parainfluenzae strains in recent
years (36, 37).
H. influenzae is known to produce a polysaccharide capsule, which can be classified
into six serotypes (Hia through Hif) and is an invasive virulence determinant (38). Strains
that do not produce the capsule are designated nontypeable H. influenzae (NTHi). The
introduction of the highly effective Hib conjugate vaccines caused a marked reduction of
Hib-related disease incidence but consequently resulted in an increased prevalence of
NTHi-related disease (39); NTHi is now more commonly isolated from children with CF
than any encapsulated H. influenzae serotype (40, 41). H. parainfluenzae is generally less
well characterized, and the role it may have in CF disease is unclear. There is no detailed
description of encapsulated H. parainfluenzae, although there is increasing evidence that
some H. parainfluenzae strains could express a polysaccharide capsule (37). Moreover,
there is a stark lack of H. parainfluenzae genomic data compared with H. influenzae, de-
spite that it occupies a similar niche. Here, we investigate the prevalence, genomic diver-
sity, and AMR phenotypes of H. influenzae and H. parainfluenzae colonizing the airways of
children with CF, recruited at the Royal Children’s Hospital (RCH), Melbourne, Australia.
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Detection and sequencing of Haemophilus isolates. During the 1-year study pe-
riod, 147 AREST CF study participants receiving treatment at the RCH CF specialist clinic
were screened for the presence of H. influenzae or H. parainfluenzae in the respiratory
tract during regular clinic visits and during hospitalization for pulmonary exacerbation.
Participant characteristics are given in Table 1. Thirty (20.4%) participants tested culture
positive for colonization with H. influenzae in $1 sample and 111 (75.5%) participants for
H. parainfluenzae. Only 29 participants (19.7%) had no Haemophilus-positive samples;
these individuals did not differ by age or gender but contributed fewer samples each
(mean 4.6 versus 6.0, P=0.012 using two-sample Kolmogorov-Smirnov test). The overall
frequency of colonization per visit was 4.6% for H. influenzae and 32.1% for H. parainfluen-
zae, with 86 participants (58.5%) presenting with either H. influenzae or H. parainfluenzae
on 2 or more occasions. Several participants had both H. influenzae and H. parainfluenzae
detected during the same (n=10, 6.8%) or different (n=15, 10.2%) visits.
A subset of 162 Haemophilus isolates from 59 participants (50% of culture-positive
individuals, representative in terms of age and gender) (see Table 1) were subjected to
whole-genome sequencing (WGS), of which 89.5% were sequenced successfully. WGS
data revealed some species misidentifications (5.5%) and mixed cultures (13%), leaving
24 H. influenzae and H. parainfluenzae isolates for further analysis (see Fig. S1 online at
doi.org/10.26188/14954931 and Materials and Methods).
Genetic diversity and population structure. The H. influenzae isolates collected in
this study were highly diverse (median of 2.3% nucleotide divergence in conserved
core genome), and a comparison with publicly available WGS data from other studies
(n=877 genomes, see Data Set S1 in the supplemental material) indicates RCH CF isolates
are distributed across the global species phylogeny (red tips in Fig. 1A). All but two RCH CF
H. influenzae genomes had no detectable capsule biosynthesis (cap) locus and fell outside
the small number of lineages typically associated with encapsulation (42) (colored branches
in Fig. 1A); they are thus predicted to be unencapsulated or nontypeable. Two RCH CF isolates
(drug susceptible, sequence type 18 [ST18], from the same patient) carried intact copies of the
cap-e locus and fell within the lineage typically associated with serotype e (green branches in
Fig. 1A); thus, they are predicted to express serotype e capsules.
We used discriminant analysis of principal components (DAPC) to explore how the
population of RCH CF H. influenzae isolates compared with the global H. influenzae popu-
lation structure captured by k-mer profiles of publicly available WGS data from a range of
other contexts (see Data Set S1; see Fig. S4 online at doi.org/10.26188/14954931). The





Participants with WGS data
(WGS species identification)
All participants
No. of total participants 147 59
No. of females (%) 64 (43.5) 23 (38.9)
Mean age at first sample, yrs (range) 5.7 (0.08–11.8) 4.1 (0.10–8.9)
Mean no. of samples, count (range) 5.8 (1–12) 6.2 (2–12)
No. with$1 H. influenzae-positive sample (%) 30 (20.4) 21 (35.6)
No. with$1 H. parainfluenzae-positive sample (%) 111 (75.5) 55 (93.2)
No. with Zero H. influenzae- or H. parainfluenzae-positive samples (%) 29 (19.7)
Participants with$1 Haemophilus culture-positive sample
No. of total participants 118 59
No. of females (%) 54 (45.8) 23 (39.0)
Mean age at first sample, yrs (range) 5.3 (0.08–11.8) 4.1 (0.10–8.9)
Mean no. of samples (range) 6.0 (2–12) 6.2 (2–12)
Mean no. of H. influenzae-positive samples (range) 0.3 (0–3) 0.5 (0–3)
Mean no. of H. parainfluenzae-positive samples (range) 2.3 (0–7) 2.8 (0–7)
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data indicate that our Australian pediatric CF isolates are typical of noninvasive respiratory
isolates from children in other settings, based on functions constructed to discriminate these
parameters from isolates collected from adults, nonrespiratory specimens, and invasive disease
(Fig. 2A to C). RCH isolates clustered most closely with other Australian isolates in the discrimi-
nant function based on geographical location (Fig. 2D). Notably, DAPC analysis of the 264,940
core-genome single nucleotide variants (SNVs) used for phylogenetic inference yielded much
weaker discriminant functions for specimen type and geographical location (see Fig. S5 online
at doi.org/10.26188/14954931), suggesting that the discriminant genetic features are carried in
the accessory genome rather than core gene allelic variation.
The H. parainfluenzae isolates collected in this study also show extensive genetic di-

















FIG 1 Maximum likelihood phylogenies for H. influenzae (A) and H. parainfluenzae (B). Trees were inferred from alignments of
core genome SNVs, showing the relationship between RCH isolates (red tips) and publicly available genome collections
(summarized in Table S1 online at doi.org/10.26188/14954931). Shading indicates strain clusters of RCH isolates involved in
potential transmission or persistence (see Fig. 4).
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harder to contextualize within the overall species diversity due to the low number of
genomes available from other studies but appears to be representative of species-wide
phylogenetic diversity (Fig. 1B).
Antimicrobial resistance. AMR was relatively common, with 52% of H. influenzae
and 82% of H. parainfluenzae isolates displaying resistance to at least one of the five
drugs tested (Table 2). The frequency of cotrimoxazole (STX) resistance was similar in
both species (35% in H. influenzae, 31% in H. parainfluenzae), but ampicillin and/or aug-
mentin (AMC) resistance was observed at significantly higher rates in H. parainfluenzae
than those in H. influenzae (P, 0.05) (see Table 2). Rifampicin (RIF) was observed at low
frequencies in both species (17% in H. influenzae, 7% in H. parainfluenzae). Multidrug re-
sistance (defined here as resistance to ampicillin or augmentin plus at least one other
drug class) was also more commonly detected in H. parainfluenzae, although the difference
was not statistically significant (see Table 2).
We used the WGS data to explore genetic determinants of AMR in the RCH isolates.
Horizontally acquired AMR genes were more frequently found in H. parainfluenzae
than in H. influenzae, with 42 (51%) H. parainfluenzae and 5 (21%) H. influenzae isolates
containing one or more acquired AMR genes (P=0.0107 using Fisher’s exact test) (see
DATA SET S2 in the supplemental material). Most common were blaTEM genes (36 blaTEM-
1, 4 blaTEM-40, and 2 blaTEM-30), carried in the mobile element ICEHin (2 H. influenzae, 38 H.
parainfluenzae) or small plasmids (3 H. influenzae, 2 H. parainfluenzae). Other AMR genes
were less common and restricted to H. parainfluenzae, which were generally located in
ICEHin elements (11 isolates carried strAB [aminoglycosides] and sul1 [sulfonamide-cotrimox-
azole], 5 aph3’la [aminoglycosides], 1 tetB [tetracycline], and 1 tetM [tetracycline] with msrD
and mefA [macrolides]). The resistance cassettes of ICEHin varied in structure and gene con-
tent (Fig. 3A). Four distinct blaTEM plasmids were observed and were of a similar size (4.3 to




























































FIG 2 Discriminant analysis of principal components for H. influenzae isolates. Analyses were based on k-mer profiles extracted from the
genomes of novel Australian CF pediatric respiratory colonizing isolates sequenced for this study (labeled RCH, black) and those available in
public genome collections (other colors; data sources are summarized in Data Set S1). Plots show the distribution of values for the significant
linear discriminants (LD1 and LD2) included in the linear discriminant functions, which were constructed to discriminate genomes on the
basis of host age (A), infection status (invasive or noninvasive/colonizing) (B), specimen type (C), and country of isolation (D).
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pLFH64 (2 H. influenzae, blaTEM-1), pA1209 (one H. influenzae, blaTEM-1), pPN223 (one H. parain-
fluenzae, blaTEM-1); the fourth was a novel plasmid present in one H. parainfluenzae isolate
(pM1C124_1, blaTEM-40; deposited in GenBank under accession MW111541) (Fig. 3B; see Table
S4 online at doi.org/10.26188/14954931). Acquired AMR genes accounted for only 33.6% of
observed nonsusceptibility phenotypes; hence, we screened for mutations in conserved
core resistance-related chromosomal genes that could potentially explain resistance to ampi-
cillin and augmentin (pbp genes) (see Table S3 online at doi.org/10.26188/14954931), cotri-
moxazole (folP and folA), and rifampicin (rpoB) (summarized in Tables S5 and S6 at doi.org/
10.26188/14954931).
Ampicillin resistance in H. influenzae could be entirely explained by acquired b-lactamases
encoded by blaTEM genes (57%) and/or mutations in the penicillin-binding proteins PBP3 (FtsI)
and PBP1B (MrcB) (Table S5 online at doi.org/10.26188/14954931). In H. parainfluenzae,
acquired blaTEM could explain 60% of ampicillin resistance, but we detected no known or
novel PBP mutation that was statistically associated with resistance (Table S6 online at doi
.org/10.26188/14954931). Notably though, the first H. parainfluenzae isolated from partici-
pant M1C152 was ampicillin sensitive and wild type at PBP3-502. The two subsequent H.
parainfluenzae isolates from this participant (following treatment with augmentin and
ceftriaxone) were ampicillin resistant with no acquired AMR genes and differed from the
TABLE 2 Frequency of nonsusceptibility to antimicrobials among sequenced isolatesa
Antimicrobial
No. (%) positive for:
Odds ratio (95% CI) P valueH. influenzae H. parainfluenzae
Ampicillin 7/23 (30) 60/82 (73) 6.11 (2.05–20.09) 0.0004
Augmentin 1/17 (6) 25/79 (32) 7.30 (1.02–322.38) 0.0351
Cefotaxime 0/23 (0) 2/81 (3) Inf (0.053–Inf) 1
Cotrimoxazole 8/23 (35) 25/82 (31) 0.82 (0.28–2.55) 0.8002
Rifampicin 2/12 (17) 4/59 (7) 0.37 (0.045–4.61) 0.2659
Ampicillin or augmentin 7/17 (41) 62/78 (80) 5.41 (1.58–19.72) 0.0026
One or more drugs tested 12/23 (52) 68/83 (82) 4.09 (1.36–12.47) 0.0058
MDR 5/23 (22) 23/83 (28) 1.38 (0.42–5.30) 0.7897
aNonsusceptibility was defined as I or R according to clinical breakpoints (see Materials and Methods). Multidrug
resistance (MDR) was defined as resistance to ampicillin or augmentin plus at least one other antimicrobial.
Association tests compare resistance rate between species and were performed using Fisher’s exact test. The analysis
is restricted to isolates that were successfully sequenced, had a susceptibility phenotype reported for the given

































































































FIG 3 Representative ICEHin structures (A) and plasmids (B) carrying AMR genes identified in RCH isolates. Plasmids are annotated with the
best corresponding match in the NCBI nucleotide database, see Table S3 online at doi.org/10.26188/14954931.
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first by a single SNV across the entire genome resulting in the amino acid substitution
PBP3-A502T, supporting the previously reported role of this mutation in conferring resist-
ance (43). Nevertheless, our findings leave 33% of ampicillin resistance in H. parainfluen-
zae unexplained.
Augmentin is a combination of amoxicillin plus the b-lactamase inhibitor clavulanic
acid. Just four augmentin-resistant isolates (16%) carried inhibitor-resistant b-lacta-
mase alleles (2 H. parainfluenzae with blaTEM-30, 2 H. parainfluenzae with blaTEM-40). Nine
more isolates (36%) carried blaTEM-1, but this encoded b-lactamase is susceptible to
clavulanic acid inhibition and we identified no pbp variants in these isolates that were
significantly associated with augmentin resistance; hence, inhibitor resistance remains
unexplained in these cases. Two augmentin-resistant H. parainfluenzae isolates col-
lected from the same participant (M1C141) contained novel blaTEM alleles that share
substitution mutations with known inhibitor-resistant alleles (blaTEM-1-M67I, blaTEM-1-
W163L) (Fig. S6 online at doi.org/10.26188/14954931), which likely explain the pheno-
type (44, 45). Hence, the vast majority of augmentin resistance (100% in H. influenzae,
80% in H. parainfluenzae) is unexplained. Resistance to the third-generation cephalo-
sporin cefotaxime (CTX) was observed in two H. parainfluenzae isolates from different
participants but was unexplained (one carried no acquired genes, one carried only
blaTEM-1, and neither carried unique pbpmutations).
Cotrimoxazole is a combination of trimethoprim and sulfamethoxazole. Resistance to
trimethoprim is associated with mutations in the chromosomal dihydrofolate reductase
folA or acquisition of mobile resistant alleles (dfr genes), while resistance to sulfamethox-
azole requires mutations in the chromosomal dihydropteroate synthase folP or acquisi-
tion of mobile resistant alleles (sul genes). In H. influenzae, no acquired sul or dfr genes
were detected; however, all cotrimoxazole-resistant isolates carried a novel resistance-
associated mutation, FolA-N13S, and most carried the novel FolP-G189C (75%), as well as
previously reported FolA-I95L (75%) and FolP-P64ins (38%) (Table S5 online at doi.org/10
.26188/14954931, and Data Set S2). In H. parainfluenzae, 92% of cotrimoxazole-resistant
isolates carried sul1 (36%) and/or resistance-associated FolP mutations (including FolP-
P64ins and FolP-G189C, 80%); 64% carried resistance-associated FolA mutations (46)
(Table S6 online at doi.org/10.26188/14954931, and Data Set S2).
Rifampicin resistance is most often explained by mutations in rpoB (the RNA polymerase
beta subunit), including one previous report in H. influenzae (47). Both rifampicin-resistant H.
influenzae isolates (from the same patient, M1C073) carried a novel mutation, RpoB-A1131T,
that was absent from sensitive isolates. In H. parainfluenzae, one of four rifampicin-resistant
isolates (M1C081_2) carried RpoB-T724I, which has been previously described in resistant H.
parainfluenzae isolates (19); however, the remaining three isolates contained no other muta-
tions associated with rifampicin resistance (Data Set S2).
Persistent colonization and transmission. Seventy-nine participants (53.7%) were
culture positive for the same Haemophilus species on $1 occasion; 7 (4.8%) partici-
pants had $2 H. influenzae and 75 (51%) had $2 H. parainfluenzae. The probability of
testing culture positive for the same species in the next sample after an initial positive
result (mean time interval 105 days) was 16.0% for H. influenzae and 48.1% for H. para-
influenzae (P = 0.004 for test of difference in proportions). Among those individuals
who had a culture-positive sample directly followed by a culture-negative for the same
species (n=107), 36 (33.6%) had a subsequent positive sample and 11 (10.3%) had no
further samples tested. In 45/79 participants, WGS data were available for at least 2 iso-
lates of the same species. Among these patients with $2 WGS sequences, 13 partici-
pants (29%) had matching isolates of the same strain (defined as #20 mutations; see
Materials and Methods), consistent with persistent colonization (2 H. influenzae and
11 H. parainfluenzae) (see Fig. 4A). Assuming the same rate of strain matching (29%)
among the 34 participants who had $2 isolates but WGS data was available for only 1
of those isolates, we estimate that a further 10 of these participants would have matching
strains. Thus, we estimate a total of 23 (15.6%) of the 147 participants (95% confidence inter-
val [CI], 8.4% to 22.6%) had Haemophilus colonization that persisted between visits. Notably,
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the only encapsulated strain detected in this study (cap-e H. influenzae) was detected twice
in the same participant (M1C094), on two separate clinic visits 84days apart.
WGS data showed that most strains were unique to a single participant; however, we iden-
tified 6 participant pairs that shared the same strain (1 to 19 mutations, see Materials and
Methods; 3 H. influenzae, 3 H. parainfluenzae) (see Fig. 4B), suggesting potential transmission.
In three such cases, both participants visited an RCH CF clinic on the same day (Fig. 4B), pro-
viding a potential opportunity for transmission within the clinic. A contact network recon-
structed from visit dates showed that while the other three strain-sharing participant pairs
never attended on the same day, they did have shared visit days with single-step intermediary
participants (Fig. S7 online at doi.org/10.26188/14954931); hence, it is possible that one of
these intermediary participants had become colonized at the clinic via the first participant
and then passed the strain on to the second participant on a subsequent visit.
Twelve of the 13 (92%) WGS-confirmed cases of persistent strain colonization exhibited re-
sistance to at least 1 drug, compared with 70% of strains that were not identified as persisting







































Q1 Q2 Q3 Q4 Q1
2016 2017
Legend
Species Hi Hpi No WGS
Timeline Participant Other strains
Target strain
FIG 4 Timelines of Haemophilus isolation for participants affected by persistent colonization (A) or potential
transmission between participants (B). Triangles indicate Haemophilus isolates that are colored according to WGS-
confirmed species as per inset legend. Isolates presented above each timeline represent the same strain (defined as
pairwise genetic distance ,20; see Materials and Methods) and those below are different strains. Dist, range of
pairwise genetic distances (nonrecombinant SNVs 1 number of inferred recombination events) observed between
isolates of the same strain. In B, lines connecting participant timelines represent instances where participants attended
an RCH clinic during the same day. Shared days, number of days on which both participants attended the RCH CF
clinic; 1° intermediaries, for participant pairs not sharing any clinic visit days with one another, we searched for
primary intermediary participants who shared at least one clinic data point with each of the participants.
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AMR phenotypes were more frequent among isolates associated with persistent strain coloni-
zation; however, these comparisons were underpowered, and the differences were only statis-
tically significant for ampicillin, augmentin, and cefotaxime (Table S7 at doi.org/10.26188/
14954931). Five of the six potentially transmitted strains displayed at least one AMR pheno-
type, similar to the overall rate of AMR across all colonizing isolates (Table S8 online at doi.org/
10.26188/14954931) (Data Set S2). Changes in AMR phenotypes within individual H. influenzae
or H. parainfluenzae strains were observed during both persistent colonization (resistance phe-
notypes varied in 8/13 individuals, 62%) and transmission chains (resistance phenotypes varied
in 4/6 transmission pairs, 67%), indicating short-term evolution of resistance (Data Set S2).
DISCUSSION
H. influenzae and H. parainfluenzae colonization of the airways was strikingly com-
mon in this cohort, with .80% of participants contributing $1 Haemophilus culture-
positive respiratory sample during the 1-year period of study (Table 1) and 58.5% con-
tributing $2 such samples. The point prevalence was 4.6% for H. influenzae and 32.1%
for H. parainfluenzae, and repeat colonization with H. parainfluenzae was much more
common than that with H. influenzae (detected in 51% and 4.8% of participants,
respectively). H. parainfluenzae also displayed a significantly higher frequency of AMR
(Table 2), which was perhaps linked to its increased carriage rate. Globally, the H. influ-
enzae carriage rate in children varies, likely due to differences in cohort demographics
and geographical location. H. influenzae has been reported to be recoverable from the
nasopharynx in 8% to 34% of children with CF (40, 48–52), consistent with H. influenzae
carriage estimation in this CF cohort. The frequency of H. parainfluenzae airway coloni-
zation has not been established in children (with or without CF) despite the potential
to opportunistically cause disease and act as a reservoir for AMR genes.
Substantial genetic diversity was observed for both H. influenzae and H. parainfluenzae
isolates cultured from the airways of participants in this study (Fig. 1). Unsurprisingly,
only two H. influenzae isolates (from a single patient) were predicted to be encapsulated
(cap-e); they belonged to a known clonal capsule-positive lineage (ST18). The remaining
H. influenzae isolates belong to the highly heterogenous NTHi group, similar to those
detected in other studies examining nasopharyngeal colonization, which consistently
report NTHi as the dominant H. influenzae subtype in the respiratory tract (40, 41).
An analysis of H. influenzae core-genome SNVs using phylogenetics and DAPC showed
no apparent lineage associations with age group, specimen type, disease status, or geo-
graphical location (Fig. S4 and S5 online at doi.org/10.26188/14954931). This finding is
consistent with prior studies of NTHi which reported finding no evidence for phylogenetic
signals of geographical origin (53, 54) or clinical source (54, 55). However, whole-genome
k-mer DAPC revealed distinct clustering of RCH CF isolates with others that were noninva-
sive, collected from the respiratory tract, isolated from children, and circulating in
Australia (based on the respective individual discriminant functions, see Fig. 2). Hence, H.
influenzae isolates of distinct epidemiological origins are differentiable based on variation
in accessory genes but not by allelic variation in the core genome.
The structured variability across the accessory genome could potentially be explained
by niche-specific positive selection of genes that confer increased fitness. For example,
fixation of ICEHin1056 in respiratory H. influenzae populations has been previously
observed within 2 weeks of amoxicillin treatment but subsequently lost (or resistant
strains outcompeted) 12 weeks after the initial treatment (56). The Hia and HMW adhe-
sins, Hif pilus, and IgA proteases are H. influenzae virulence factors that are also differen-
tially present in strains (53, 57) and play a role in the colonization of specific niches like
the respiratory tract (58–61). Genome-wide association analysis could potentially identify
other contributing factors (62); however, this identification is beyond the scope of the
present study.
Antimicrobial therapy is used routinely both to control bacterial lung infections of CF
patients (63) and also as an antimicrobial prophylaxis. Augmentin is routinely used for
both of these purposes. Cotrimoxazole is used at many specialist CF centers, but it is not
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routine at RCH; however, resistance was still observed in nearly a one-third of H. influen-
zae and H. parainfluenzae. Regular use of antimicrobials is known to induce resistance,
and indeed, we observed a high rate of AMR in isolates collected in this study, with resist-
ance to one or more drugs observed in 52% H. influenzae and 82% H. parainfluenzae
(Table 2). AMR rates in H. influenzae isolated from the respiratory tract in non-CF patients
vary between studies, with recent reports of ampicillin resistance at 23.9% to 58.5%, aug-
mentin at 0% to 10.4%, cefotaxime at 0% to 5.9%, cotrimoxazole at 51.2% to 71.1%, and
rifampicin at 0% and 4.8% (18–27). Similar rates have been reported for H. parainfluenzae
in non-CF patients, as follows: for ampicillin, 13.2% to 18.5%; augmentin, 0% to 12.5%;
cefotaxime, 0% to 0.3%; cotrimoxazole, 14.9% to 44.2%; and rifampicin, 26.7% (28–30).
AMR rates detected in the present study are mostly in line with rates in these reports,
with the exception of higher rates of resistance in H. parainfluenzae versus H. influenzae.
The only other report of such a difference is an earlier study in our setting (children with
CF at RCH, 1998 to 2012) (31), which also found higher rates of resistance in H. parainfluen-
zae than in H. influenzae and showed that rates of ampicillin, augmentin, and cotrimoxazole
resistance increased significantly in H. parainfluenzae over the 15-year duration of the study.
Most of the AMR phenotypes were explained by the presence of known genetic deter-
minants. Ampicillin resistance was the most readily explained by known mechanisms,
with all H. influenzae-resistant isolates and 67% of H. parainfluenzae-resistant isolates har-
boring the acquired gene blaTEM or resistance-associated mutations in PBP genes (Data
Set S2). The exceptions were augmentin and ceftriaxone; inhibitor-resistant blaTEM alleles
accounted for just 20% of augmentin resistance in H. parainfluenzae and none in H. influ-
enzae, and no mechanisms for ceftriaxone resistance were identified.
Novel mutations in AMR-associated proteins discovered through association analy-
sis increased the proportion of resistance explained by amino acid substitutions from
13.4% to 31.3%. Several mutations in FolA and FolP were associated with cotrimoxa-
zole resistance (Table S5 and S6 online at doi.org/10.26188/14954931), including both
novel and previously established mutations (46). Notably, we identified an insertion in
H. parainfluenzae FolP that was strongly linked with cotrimoxazole resistance and
shared the same location as the H. influenzae FolP-P64ins mutation, which has been
demonstrated to induce sulfamethoxazole resistance (64). Mutations for rifampicin re-
sistance were identified in H. influenzae (RpoB-A1131T) and H. parainfluenzae (RpoB-
T724I); the latter was also recently reported as resistance associated in an independent
study of H. parainfluenzae (19).
Consistent with previous studies, nearly all acquired genes detected here in
Haemophilus isolates were localized to either an ICEHin element (65, 66) or small
blaTEM plasmids (34, 44, 67). Novel variants of acquired resistant determinants were
also observed, including a new ICEHin-encoded blaTEM allele associated with aug-
mentin resistance in H. parainfluenzae and a novel plasmid harboring blaTEM-1.
Not all AMR could be explained by an underlying genetic component. This result is
likely due in part to a lack of statistical power for detecting novel resistance-associated
variants, even when taking a candidate-gene approach as we did, due to the small
sample size. This limitation is particularly problematic for H. influenzae, for which only
24 sequenced isolates were available; for example, FolP-G189C was associated with
cotrimoxazole resistance in both H. influenzae and H. parainfluenzae but was statisti-
cally significant only in H. parainfluenzae after adjustment for multiple testing (Table S5
and S6 online at doi.org/10.26188/14954931). Additionally, AMR phenotypes are not
always reproducible, and AMR genes or mutations can be lost during subculture to
extract DNA for sequencing. Moreover, it is conceivable that some single chromosomal
mutations reported here are alone insufficient to confer resistance and instead may
require a stepwise acquisition of additional mutations before resistance is gained.
A small number of isolates originally identified biochemically as H. influenzae were
found to be H. parainfluenzae via WGS (n=3) and vice versa (n=5; Fig. S1 online at doi
.org/10.26188/14954931). The definitive underlying cause of this discrepancy is unclear
but could be explained by several possibilities, including the presence of both H. influenzae
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and H. parainfluenzae in the same sample or inaccuracies in the biochemical species identifica-
tion test. The overall rate of discordance between biochemical and genomic species identifica-
tion was#7%, suggesting that studies of H. influenzae colonization or infection that rely solely
on biochemical identification without additional confirmation may suffer from both false pos-
itives and false negatives. There is little published data on the persistence of Haemophilus col-
onization in the lungs of children; however, there is some evidence that H. influenzae strain
persistence is associated with chronic respiratory disease and does not occur in healthy child-
hood cohorts (68). This study reveals for the first time strain persistence of H. influenzae and
H. parainfluenzae in the lungs of children with cystic fibrosis for up to 349days and estimates
the carriage rate of persistent strains in the cohort to be 15.6% (95% CI, 8.4% to 22.6%). Strain
persistence likely arises due to substantial selective pressure exerted by extensive and pro-
longed administration of antimicrobials or niche adaptation to the diseased lung. For exam-
ple, mutations in the single-strand mispairing mechanism allow H. influenzae to alter the
expression of nutrient uptake systems and surface molecules, such as adhesins, during persis-
tent colonization in adult patients with chronic obstructive pulmonary disorder (54). Other im-
portant CF pathogens, such as P. aeruginosa and members of the Burkholderia cepacia com-
plex, have been shown to undergo similar changes to surface molecules and remodeling of
regulatory networks during persistence (69–71). In addition to strain persistence, we observed
that participants were frequently colonized by different strains of H. influenzae and H. parain-
fluenzae across clinic visits, indicating that Haemophilus colonization is a dynamic process and
suggesting that strains of both species compete to occupy the niche.
There were six instances where participants shared the same Haemophilus strain.
Three of the six cases were supported by epidemiological links whereby participants
shared clinic visit days (Fig. S7 online at doi.org/10.26188/14954931), and the remain-
ing three cases shared visit days with possible intermediaries (Fig. S7 online at doi.org/
10.26188/14954931). Nosocomial transmission of CF pathogens, such as P. aeruginosa,
has been demonstrated in other settings (71, 72) and historically at our center (73, 74), as has
cross-infection with Mycobacterium abscessus (75). These findings have led to strict infection
control practices in CF clinics such as RCH with strict isolation in both clinics and inpatient
areas, wearing of face masks by patients in all public spaces, and strict gloving and gowning
by all clinical staff. Notably, preceding the introduction of such stringent infection-control
measures, sharing of RCH CF clinic visit days was common in our cohort, and nearly all partici-
pant pairs could be connected either through a shared clinic visit day (15%) or shared visit
days with a single intermediary (72.4%). Hence, it is not clear whether the overlap in visit days
could be circumstantial or strain sharing may reflect circulation of strains in the general com-
munity rather than nosocomial transmission. Future studies in settings where fewer patients
share visit days may be better able to differentiate these possibilities.
This study provides the first insights into the population dynamics and genomic
determinants of AMR among colonizing H. influenzae and H. parainfluenzae strains in a
pediatric CF cohort and identifies multiple novel AMR determinants particularly for H.
parainfluenzae. Notably, while relatively little attention has been paid to H. parainfluen-
zae colonization in children due to its relative lack of pathogenicity, our data indicate it
is a common colonizer that can persist in the respiratory tract of CF children and is
very frequently drug resistant. The high frequency of AMR in H. parainfluenzae, of
which most was encoded in mobile elements that can transfer to H. influenzae, indi-
cates that H. parainfluenzae could serve as a reservoir for the emergence and spread of
AMR to H. influenzae which is of more significant clinical concern in children with and
without CF. Further insights are essential and will inform antimicrobial treatment and
stewardship in the future. Understanding the role of H. influenzae and H. parainfluenzae
in early CF disease progression falls within the province of the AREST CF program
goals, and additional studies will aim to assess and explore the specific risk factors
associated with early lung colonization by these Haemophilus species.
MATERIALS ANDMETHODS
Participant recruitment and sample and data collection. Participants in this study are a subset of
those enrolled in the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) birth
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cohort who meet the following inclusion criteria: diagnosed with CF, under 12 years of age, resident in
catchment area, and presented to the RCH CF clinic between February 2016 to February 2017 (16).
Respiratory samples (bronchoalveolar lavage [BAL] fluid, sputum, or cough swabs) were routinely col-
lected from participants during regular visits and cultured on chocolate agar in the RCH microbiological
diagnostics laboratory as previously described (16). During the 1-year study period, 847 samples col-
lected from 147 study participants were analyzed and yielded 39 isolates identified as H. influenzae and
272 identified as H. parainfluenzae (identified using the X and V factor test). Isolates were tested for sus-
ceptibility to ampicillin (AMP), augmentin (AMC), cefotaxime (CTX), cotrimoxazole (STX), and rifampicin
(RIF) using disk diffusion with CLSI breakpoints (Table S1 online at doi.org/10.26188/14954931).
Bacterial isolates, sequencing, and assembly. A total of 162 of the 311 Haemophilus isolates (n= 30,
77% of those biochemically identified as H. influenzae; and n= 132, 48.5% as H. parainfluenzae) were suc-
cessfully resuscitated, subcultured, and transferred to the University of Melbourne for whole-genome
sequencing (WGS). Isolates were plated onto chocolate agar and incubated at 37°C under microaero-
philic conditions for 48 hours. Colonies were harvested and DNA extracted using GenFindV2 (Beckman
Coulter), using proteinase K for bacterial lysis according to the manufacturer’s instructions. Short-read
DNA libraries were prepared for all isolates with a Nextera XT kit (Illumina) and subsequently sequenced
on the Illumina MiniSeq platform, generating paired-end reads of 151 bp each. DNA samples for long-
read sequencing were prepared for a subset of 14 isolates using GenFindV2 (Beckman Coulter); a bar-
coded ligation library was prepared (SQK-LSK108, EXP-NBD103) and sequenced via an Oxford Nanopore
MinION device on a R9.4.1 flow cell.
A total of 107 isolates (24 H. influenzae, 83 H. parainfluenzae) were successfully sequenced via
Illumina and passed quality control, each yielding $150,000 high-quality reads (Fig. S1 online at doi.org/
10.26188/14954931, and Data Set S1). Centrifuge v1.0.4b (76) was used to categorize isolates as either (i)
pure H. influenzae or H. parainfluenzae, defined as one of these species at $50% relative abundance and
the next most common species ,20% relative abundance; (ii) contaminated H. influenzae or H. parain-
fluenzae, defined as one of these species at $50% relative abundance and a second species also highly
represented ($20% relative abundance); or (iii) other, where neither of these species exceeded 50% rela-
tive abundance (Fig. S1 online at doi.org/10.26188/14954931). Strain multiplicity for pure H. influenzae
and H. parainfluenzae cultures was assessed by comparing the ratio of heterozygous to homozygous sin-
gle nucleotide variant (SNV) calls (methods below) against an empirically determined threshold (H. influ-
enzae, $0.025; or H. parainfluenzae, $0.100, calculated from public data sets); samples exceeding this
threshold were considered mixed cultures and were excluded from further analysis (Fig. S1 online at doi
.org/10.26188/14954931). Genomes were assembled with Unicycler v0.4.7 (77), using Illumina data in all
cases and complemented by MinION data where available. All AMR plasmid sequences (listed in Table
S4 online at doi.org/10.26188/14954931) were identified as circularized contigs in the assembly graphs.
Read data and assemblies were deposited under the NCBI BioProject accession PRJNA668428 (see Data
Set S1 for individual accessions).
Population structure analysis. The H. influenzae and H. parainfluenzae short-read Illumina data gen-
erated in this study (n= 107), and publicly available read sets for previously sequenced genomes of
these species (n= 891; summarized in Table S2 online at doi.org/10.26188/14954931), were subjected to
SNV detection, phylogenetic, and population structure analyses. SNVs (biallelic and polyallelic) were
called using Bowtie2 v2.2.9 (for read mapping) and SAMtools v1.9 (for variant calling) via the RedDog
pipeline v1beta.11 (https://github.com/katholt/reddog), using H. influenzae strain Rd KW20 (accession
GCA_000027305.1) and H. parainfluenzae strain T3T1 (accession GCA_000210895.1) as reference
genomes. For each species, core SNV alleles were defined as SNV alleles present in $95% genomes.
Maximum likelihood conserved core-genome SNV phylogenies were inferred from alignments of core
SNV alleles (263,940 [85.3% of all detected SNV] for 901 H. influenzae genomes and 329,046 [79.1% of all
detected SNV] for 97 H. parainfluenzae genomes) using IQ-TREE v2.1.0 (78). Phylogenies were visualized
with ggtree v1.14.6 (79) in R v3.5.2 (80). H. influenzae capsular serotype loci were detected from genome
assemblies using hicap v1.0.0 (42), and sequence types (STs) were assigned to H. influenzae read sets
using SRST2 v0.2.0 (81) with the H. influenzae multilocus sequence typing (MLST) database (82) (https://
pubmlst.org/organisms/haemophilus-influenzae).
Discriminant analysis of principal components (DAPC) (83) was conducted to explore the relationship
between bacterial population structure and sample source using k-mers (of length k=16) extracted from
assemblies. Frequencies of k-mers were counted in each assembly with fsm-lite v1.0 (https://github.com/
nvalimak/fsm-lite), and a presence-absence matrix was constructed. Due to memory limitations, random
sets of 500,000 k-mers were selected from the presence-absence matrix to use as input for DAPC, which
was performed with the R package adegenet v2.1.1 (84) in triplicate using different random k-mer subsets
to ensure stability of results (and additionally using the core-genome SNVs called from reads).
Analysis of antimicrobial determinants. RCH isolates were investigated for known and novel AMR
determinants. Reads and assemblies were screened using SRST2 v0.2.0 and BLAST v2.7.1, respectively, to
identify alleles of horizontally transferred AMR genes curated in the ARG-ANNOT database (85). Exact
matches for translated blaTEM gene sequences were identified in the NCBI AMR database with BLAST to
infer the spectrum of activity and inhibitor resistance.
Mutations in chromosomally encoded antimicrobial target genes (ftsI, folA, rpoB, and pbp genes) (43,
44, 46, 64, 86–92) were also investigated. An exhaustive search for PBP genes present in the H. influenzae
and H. parainfluenzae reference genomes was performed by aligning translated gene sequences to all cura-
ted PBP protein sequences available in the Swiss-Prot database (93) to identify those with $80% coverage
and $70% identity (Table S3 online at doi.org/10.26188/14954931). Nucleotide sequences for target genes
(ftsI, folA, rpoB, and pbp genes) were extracted from RCH isolate assemblies, and the translated amino acid
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sequences were aligned using MAFFT v7.407 (94). Each alignment position was compared to the consensus
sequence for all isolates that were sensitive to the relevant antimicrobial. Positions that varied were tested
for statistical association with the corresponding antimicrobial susceptibility phenotype (expressed as a bi-
nary variable, insensitive [I/R] versus sensitive [S]) using Fisher’s exact test and using linear mixed models
(LMMs) to correct for population structure by including a genetic relatedness matrix calculated from the
alignment of biallelic SNVs. LMMs were fitted with GEMMA v0.98.1 (95), and significance was assessed by
the Wald test. The resulting P values were adjusted for multiple testing using Benjamini-Hochberg correc-
tion on a per-gene basis. Significant variants (P, 0.05) are reported in Table S5 and S6 (available online at
doi.org/10.26188/14954931), and the distribution of variants in isolates are detailed in Data Set S2.
Identification of persistent and transmitted strains. Strains were defined as groups of closely related
isolates with a pairwise genetic distance of #20. They were identified initially using complete-linkage hier-
archical clustering based on SNV distances derived from the global conserved core-genome alignment (Fig.
S2 online at doi.org/10.26188/14954931). To capture isolate pairs with inflated SNV counts due to small
numbers of recombination events, the SNV distance thresholds for strain definition were set to #2,000 for
H. influenzae and #4,000 for H. parainfluenzae (Fig. S2A and C online at doi.org/10.26188/14954931).
Precise pairwise SNV distances within each potential strain group were obtained by mapping all isolates to
the best within-group genome assembly (lowest N50 value) using RedDog v1beta.11 as described above.
Recombination blocks were identified by comparing pairwise SNV densities within discrete 4-kbp windows
along the genome with the mean pairwise SNV count for all windows, using a binomial test and Bonferroni
correction to account for multiple testing within each strain group (Fig. S3 online at doi.org/10.26188/
14954931). Genetic distance between isolate pairs was then defined as nonrecombinant SNVs plus the
number of recombinant blocks, and strains were defined as groups of isolates with pairwise genetic dis-
tance of#20 (Fig. S2B and D online at doi.org/10.26188/14954931).
Data availability. Read data and assemblies of H. influenzae and H. parainfluenzae isolates are avail-
able through NCBI BioProject under the accession PRJNA668428. Accessions for individual isolates are
additionally listed in Data Set S1.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
DATA SET S1, XLSX file, 0.1 MB.
DATA SET S2, XLSX file, 0.03 MB.
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